#1 Startup Dataset
Growth rates, revenue data, direct competitors and contact details.
Lea David Email
Senior Medical Director; Drug Safety and Pharmacovigilance . Relypsa
Redwood City, CA
LocationPrimary Email
How to contact Lea David
Join and see Lea's contact info for free!Current Roles
Employees:
90Revenue:
$13.9MAbout
Relypsa, Inc. is a privately held biopharmaceutical company leading the discovery and development of new non-absorbed polymeric drugs for important applications in renal and cardiovascular disease. The company’s most advanced therapeutic programs include a novel potassium binder for treatment of hyperkalemia, known as ILY-105, as well as a novel sodium binder, ILY102, for the potential treatment of congestive heart failure. Relypsa is dedicated to discover additional product candidates through use of its proprietary polymer platform. To date, Relypsa has raised $33 million in Series A financing. Investors include 5AM Ventures, New Leaf Venture Partners, Delphi Ventures, CMEA Ventures and Mediphase Venture Partners.Relypsa Address
100 Cardinal WayRedwood City, CA
United States